J&J loses key tuberculosis drug patent in India
India's Patent Office rejected on Thursday US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
Mar 23, 2023
0
3